Johnson & Johnson Share Price NEO Exchange

Equities

JNJ

CA47817E1034

Pharmaceuticals

End-of-day quote NEO Exchange 23:00:00 13/06/2024 BST 5-day change 1st Jan Change
19.47 CAD -0.21% Intraday chart for Johnson & Johnson -1.42% -7.94%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 88.79B 122B 7,001B Sales 2025 * 92.1B 127B 7,263B Capitalization 350B 481B 27,619B
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 3.95 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 3.8 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 131,900
Yield 2024 *
3.31%
Yield 2025 *
3.46%
Free-Float 77.08%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.21%
1 week-1.42%
Current month-1.02%
1 month-4.93%
3 months-8.98%
6 months-6.98%
Current year-7.94%
More quotes
1 week
19.32
Extreme 19.32
19.73
1 month
19.32
Extreme 19.32
20.73
Current year
19.24
Extreme 19.24
22.16
1 year
19.24
Extreme 19.24
22.16
3 years
19.24
Extreme 19.24
22.16
5 years
19.24
Extreme 19.24
22.16
10 years
19.24
Extreme 19.24
22.16
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 31/12/88
Director of Finance/CFO 57 31/12/97
Chief Tech/Sci/R&D Officer 58 04/11/19
Members of the board TitleAgeSince
Director/Board Member 70 24/04/19
Director/Board Member 72 18/06/14
Director/Board Member 70 21/10/09
More insiders
Date Price Change Volume
14/06/24 19.47 -0.21% 5,877
13/06/24 19.51 +0.21% 3,904
12/06/24 19.47 -1.12% 7,225
11/06/24 19.69 -0.20% 2,383
10/06/24 19.73 -0.10% 6,634

End-of-day quote NEO Exchange, June 13, 2024

More quotes
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
145.5 USD
Average target price
171.7 USD
Spread / Average Target
+17.99%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW